PortfoliosLab logoPortfoliosLab logo
LYFIX vs. LOGSX
Performance
Return for Risk
Drawdowns
Volatility
Dividends

Performance

LYFIX vs. LOGSX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in AlphaCentric LifeSci Healthcare Fund (LYFIX) and Live Oak Health Sciences Fund (LOGSX). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, LYFIX achieves a -0.57% return, which is significantly higher than LOGSX's -3.06% return.


LYFIX

1D
-3.07%
1M
-1.86%
YTD
-0.57%
6M
-1.29%
1Y
33.09%
3Y*
6.91%
5Y*
5.20%
10Y*

LOGSX

1D
-1.13%
1M
-1.34%
YTD
-3.06%
6M
-2.57%
1Y
13.04%
3Y*
7.87%
5Y*
5.71%
10Y*
6.37%
*Multi-year figures are annualized to reflect compound growth (CAGR)

LYFIX vs. LOGSX - Yearly Performance Comparison


2026 (YTD)2025202420232022202120202019
LYFIX
AlphaCentric LifeSci Healthcare Fund
-0.57%28.22%-0.27%7.19%-0.92%-3.42%54.83%1.20%
LOGSX
Live Oak Health Sciences Fund
-3.06%19.63%0.16%1.21%3.71%17.59%6.01%2.01%

Correlation

The correlation between LYFIX and LOGSX is 0.69, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.69

Correlation (3Y)
Calculated over the trailing 3-year period

0.65

Correlation (5Y)
Calculated over the trailing 5-year period

0.62

Correlation (All Time)
Calculated using the full available price history since Dec 2, 2019

0.63

The correlation between LYFIX and LOGSX has been stable across timeframes, ranging from 0.62 to 0.69 - a consistent structural relationship.

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

LYFIX vs. LOGSX — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

LYFIX
LYFIX Risk / Return Rank: 5555
Overall Rank
LYFIX Sharpe Ratio Rank: 4141
Sharpe Ratio Rank
LYFIX Sortino Ratio Rank: 3939
Sortino Ratio Rank
LYFIX Omega Ratio Rank: 3535
Omega Ratio Rank
LYFIX Calmar Ratio Rank: 8484
Calmar Ratio Rank
LYFIX Martin Ratio Rank: 7777
Martin Ratio Rank

LOGSX
LOGSX Risk / Return Rank: 1414
Overall Rank
LOGSX Sharpe Ratio Rank: 1212
Sharpe Ratio Rank
LOGSX Sortino Ratio Rank: 1313
Sortino Ratio Rank
LOGSX Omega Ratio Rank: 1212
Omega Ratio Rank
LOGSX Calmar Ratio Rank: 2020
Calmar Ratio Rank
LOGSX Martin Ratio Rank: 1515
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

LYFIX vs. LOGSX - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for AlphaCentric LifeSci Healthcare Fund (LYFIX) and Live Oak Health Sciences Fund (LOGSX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


LYFIXLOGSXDifference
Sharpe ratioReturn per unit of total volatility

+0.90

Sortino ratioReturn per unit of downside risk

+1.18

Omega ratioGain probability vs. loss probability

1.31

1.17

+0.14

Calmar ratioReturn relative to maximum drawdown

3.95

1.65

+2.30

Martin ratioReturn relative to average drawdown

14.43

4.23

+10.20

LYFIX vs. LOGSX - Sharpe Ratio Comparison

The current LYFIX Sharpe Ratio is 1.86, which is higher than the LOGSX Sharpe Ratio of 0.96. The chart below compares the historical Sharpe Ratios of LYFIX and LOGSX, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


LYFIXLOGSXDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

1.86

0.96

+0.90

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

0.23

0.40

-0.18

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.40

Sharpe Ratio (All Time)

Calculated using the full available price history

0.50

0.42

+0.08

Drawdowns

LYFIX vs. LOGSX - Drawdown Comparison

The maximum LYFIX drawdown since its inception was -35.33%, smaller than the maximum LOGSX drawdown of -45.85%. Use the drawdown chart below to compare losses from any high point for LYFIX and LOGSX.


Loading charts...

Drawdown Indicators


LYFIXLOGSXDifference

Max Drawdown

Largest peak-to-trough decline

-35.33%

-45.85%

+10.52%

Max Drawdown (1Y)

Largest decline over 1 year

-8.49%

-8.13%

-0.36%

Max Drawdown (3Y)

Largest decline over 3 years

-24.22%

-14.33%

-9.89%

Max Drawdown (5Y)

Largest decline over 5 years

-32.45%

-15.03%

-17.42%

Max Drawdown (10Y)

Largest decline over 10 years

-27.28%

Current Drawdown

Current decline from peak

-4.93%

-8.13%

+3.20%

Average Drawdown

Average peak-to-trough decline

-9.87%

-7.61%

-2.26%

Ulcer Index

Depth and duration of drawdowns from previous peaks

2.32%

3.17%

-0.85%

Volatility

LYFIX vs. LOGSX - Volatility Comparison

AlphaCentric LifeSci Healthcare Fund (LYFIX) has a higher volatility of 6.64% compared to Live Oak Health Sciences Fund (LOGSX) at 3.70%. This indicates that LYFIX's price experiences larger fluctuations and is considered to be riskier than LOGSX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


LYFIXLOGSXDifference

Volatility (1M)

Calculated over the trailing 1-month period

6.64%

3.70%

+2.94%

Volatility (6M)

Calculated over the trailing 6-month period

14.56%

10.07%

+4.49%

Volatility (1Y)

Calculated over the trailing 1-year period

18.05%

14.04%

+4.01%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

22.87%

14.19%

+8.68%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

23.41%

16.13%

+7.28%

LYFIX vs. LOGSX - Expense Ratio Comparison

LYFIX has a 1.40% expense ratio, which is higher than LOGSX's 1.02% expense ratio.


Dividends

LYFIX vs. LOGSX - Dividend Comparison

LYFIX's dividend yield for the trailing twelve months is around 1.79%, less than LOGSX's 2.14% yield.


PositionTTM20252024202320222021202020192018201720162015
LOGSX
Live Oak Health Sciences Fund
2.14%2.07%2.64%6.28%0.55%7.02%7.04%0.85%15.20%6.45%2.10%15.52%
LYFIX
AlphaCentric LifeSci Healthcare Fund
1.79%1.78%2.24%2.63%4.43%12.88%2.30%0.00%0.00%0.00%0.00%0.00%

Frequently Asked Questions


LYFIX and LOGSX have a correlation of 0.69, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

LYFIX has higher volatility (6.64%) compared to LOGSX (3.70%). In terms of maximum drawdown, LYFIX dropped -35.33% vs LOGSX's -45.85%.

LYFIX currently has the higher Sharpe Ratio (1.86 vs 0.96), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for LYFIX and LOGSX

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer